A Study to Learn More About How Safe Nurandociguat is and How it Affects the Way the Body Processes Rosuvastatin and Dabigatran in Healthy Adults

Clinical trial NCT07515339 · WITHDRAWN

Trial details

NCT number: NCT07515339
Sponsor: Bayer
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Kidney Disease

Start date: 2026-04-08
Primary completion: 2026-06-26
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.